The Effect of Abaloparatide-SC on Fracture Risk Is Independent of Baseline FRAX Fracture Probability: A Post Hoc Analysis of the ACTIVE Study

McCloskey, E.V., Johansson, H., Oden, A. et al. (5 more authors) (2017) The Effect of Abaloparatide-SC on Fracture Risk Is Independent of Baseline FRAX Fracture Probability: A Post Hoc Analysis of the ACTIVE Study. Journal of Bone and Mineral Research, 32 (8). pp. 1625-1631. ISSN 0884-0431

Abstract

Metadata

Authors/Creators:
  • McCloskey, E.V.
  • Johansson, H.
  • Oden, A.
  • Harvey, N.C.
  • Jiang, H.
  • Modin, S.
  • Fitzpatrick, L.
  • Kanis, J.A.
Copyright, Publisher and Additional Information: © 2017 American Society for Bone and Mineral Research. This is the peer reviewed version of the following article: McCloskey, E. V., Johansson, H., Oden, A., Harvey, N. C., Jiang, H., Modin, S., Fitzpatrick, L. and Kanis, J. A. (2017), The Effect of Abaloparatide-SC on Fracture Risk Is Independent of Baseline FRAX Fracture Probability: A Post Hoc Analysis of the ACTIVE Study. J Bone Miner Res, 32: 1625–1631, which has been published in final form at https://doi.org/10.1002/jbmr.3163. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving.
Keywords: ABALOPARATIDE-SC; FRACTURE RISK; FRAX; OSTEOPOROSIS
Dates:
  • Published: August 2017
  • Published (online): 26 June 2017
  • Accepted: 1 May 2017
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine (Sheffield) > Division of Genomic Medicine (Sheffield) > Department of Oncology (Sheffield)
The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 26 Jan 2018 16:30
Last Modified: 26 Jun 2018 00:38
Published Version: https://doi.org/10.1002/jbmr.3163
Status: Published
Publisher: Wiley
Refereed: Yes
Identification Number: https://doi.org/10.1002/jbmr.3163
Related URLs:

Share / Export

Statistics